Philips Appoints Medical Director to the Board of MDIC, a Partnership Organization with the FDA
Carla Goulart Peron, Medical Director at Royal Philips, has been appointed to the board of directors of the Medical Device Innovation Consortium (MDIC), a public-private partnership organization founded in 2012.
Appointment of Carla Goulart Peron
Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the board of directors of the Medical Device Innovation Consortium. In her current role at Philips, she leads the global medical and scientific organization of the group and oversees the company's medical strategy. Dr. Peron has over 15 years of experience as a leader in the medical technology industry and healthcare sector.
Role of the Medical Device Innovation Consortium
The Medical Device Innovation Consortium brings together stakeholders from the medical device sector with the U.S. Food and Drug Administration (FDA) and other government partners. The organization develops research, tools, and frameworks of action designed to assist manufacturers in navigating regulatory approval and in building the necessary evidence base for coverage decisions. The MDIC board includes officials from the medical device industry, patient advocates, as well as representatives from the FDA, the Centers for Medicare and Medicaid Services (CMS), and the National Institutes of Health (NIH).
